The invention relates to devices, systems, and methods for conditioning a zirconium oxide sorbent module for use in dialysis after recharging. The devices, systems, and methods can provide for conditioning and recharging of zirconium oxide in a single system, or in separate systems.
|
1. A method of conditioning zirconium oxide, comprising the steps of:
pumping a conditioning solution through a zirconium oxide sorbent module in a flow path; and
conditioning the zirconium oxide sorbent module using the conditioning solution comprising sodium bicarbonate at a desired zirconium oxide effluent ph.
2. The method of
4. The method of
5. The method of
6. The method of
9. The method of
10. The method of
11. The method of
12. The method of
13. The method of
14. The method of
15. The method of
16. The method of
17. The method of
18. The method of
20. The method of
|
This application claims priority to U.S. application Ser. No. 15/798,233 filed Oct. 30, 2017, which claims the benefit of and priority to U.S. Provisional Patent Application No. 62/427,806 filed Nov. 29, 2016, the entire disclosures of each of which are incorporated by reference herein.
The invention relates to devices, systems, and methods for conditioning a zirconium oxide sorbent module for use in dialysis after recharging. The devices, systems, and methods can provide for conditioning and recharging of zirconium oxide in a single system, or in separate systems.
Zirconium oxide is used in sorbent dialysis to remove anionic wastes from dialysate and to capture phosphate ions that may bleed out of a zirconium phosphate sorbent material. Generally, after use, the zirconium oxide is discarded and replaced. Because zirconium oxide is expensive and rechargeable, sorbent reprocessors can treat the zirconium oxide with strong base solutions to enable reuse of the zirconium oxide material.
For reprocessing, zirconium oxide is generally removed from a sorbent cartridge, separated from other sorbent materials, treated with strong base, and then placed into a new sorbent cartridge. The known reprocessing is costly and labor intensive.
Zirconium oxide treated with strong base will consume total carbonate if used in dialysis, resulting in a basic solution unsafe for patients. Further, to simplify bicarbonate control during dialysis, the zirconium oxide and zirconium phosphate should be in an equilibrium state.
Hence, there is a need for systems and methods to condition recharged zirconium oxide to place the zirconium oxide in a state for use in dialysis. There is a further need for systems and methods that can recharge and condition the zirconium oxide within a sorbent module. There is an additional need for systems and methods to condition a recharged zirconium oxide module to an equilibrium state with a zirconium phosphate module for later use in dialysis.
The first aspect of the invention relates to a method of conditioning zirconium oxide in a zirconium oxide module. In any embodiment, the method can include the steps of pumping a conditioning solution through the zirconium oxide module in a flow path to condition the zirconium oxide module wherein the conditioning solution has sodium bicarbonate at a desired zirconium oxide effluent pH.
In any embodiment, the method can include the step of recharging the zirconium oxide in the zirconium oxide module prior to conditioning the zirconium oxide module by pumping a base solution through the zirconium oxide module.
In any embodiment, the method can include the step of pumping the conditioning solution through a zirconium phosphate module prior to pumping the conditioning solution through the zirconium oxide module.
In any embodiment, the flow path can be a dialysate flow path including the zirconium phosphate module and zirconium oxide module.
In any embodiment, the flow path can be a recharging flow path including the zirconium phosphate module and zirconium oxide module.
In any embodiment, the desired zirconium oxide effluent pH can be between 5.0 and 7.5.
In any embodiment, the method can include the step of generating the conditioning solution in the flow path.
In any embodiment, the step of generating the conditioning solution can include mixing a sodium bicarbonate solution with acid.
In any embodiment, the step of generating the conditioning solution can include mixing a sodium bicarbonate solution with carbon dioxide.
In any embodiment, the conditioning solution can be pumped through the zirconium oxide module for between 5-30 minutes.
In any embodiment, a volume of the conditioning solution pumped through the zirconium oxide module can be between 0.5 and 20 L.
In any embodiment, the method can include the step of disinfecting the zirconium oxide sorbent module by pumping a disinfectant solution through the zirconium oxide sorbent module.
In any embodiment, the step of generating the conditioning solution can comprise pumping a fluid in a dialysate flow path through a first sorbent module; the first sorbent module containing a solid sodium bicarbonate.
The features disclosed as being part of the first aspect of the invention can be in the first aspect of the invention, either alone or in combination, or follow a preferred arrangement of one or more of the described elements.
The second aspect of the invention is drawn to a system. In any embodiment the system can include a recharging flow path having at least one receiving compartment for receiving a zirconium oxide module; the at least one receiving compartment having a zirconium oxide module inlet and a zirconium oxide module outlet; a base source fluidly connected to the recharging flow path; a bicarbonate source fluidly connected to the recharging flow path; a pump for pumping fluid from the base source and the bicarbonate source through the zirconium oxide module.
In any embodiment, the system can include an acid source fluidly connected to the recharging flow path.
In any embodiment, the system can include a static mixer in the recharging flow path; wherein the static mixer is fluidly connected to the acid source and the bicarbonate source.
In any embodiment, the system can include a carbon dioxide source fluidly connected to the recharging flow path.
In any embodiment, the carbon dioxide source can be fluidly connected to the bicarbonate source by a fluid connector.
In any embodiment, the system can include a pressure sensor on the fluid connector.
In any embodiment, the system can include a pH sensor in the recharging flow path.
In any embodiment, the system can include at least a second receiving compartment in the recharging flow path for receiving a zirconium phosphate module; the second receiving compartment having a zirconium phosphate module inlet and a zirconium phosphate module outlet and a fluid connector connecting zirconium phosphate module outlet to the zirconium oxide module inlet.
In any embodiment, the system can include an acid source, a brine source, or combinations thereof, fluidly connected to the zirconium phosphate module inlet.
The features disclosed as being part of the second aspect of the invention can be in the second aspect of the invention, either alone or in combination, or follow a preferred arrangement of one or more of the described elements.
Unless defined otherwise, all technical and scientific terms used have the same meaning as commonly understood by one of ordinary skill in the art.
The articles “a” and “an” are used to refer to one or to over one (i.e., to at least one) of the grammatical object of the article. For example, “an element” means one element or over one element.
An “acid” as used can be a Lewis acid or a Brønsted-Lowry acid. A Lewis acid is capable of accepting a lone pair of electrons. A Brønsted-Lowry acid is capable of donating a hydrogen ion to another compound.
An “acid source” is a fluid or concentrate source from which an acidic solution can be obtained.
The term “base solution” refers to any aqueous solution containing hydroxide ions and a pH of greater than 7.0.
A “base source” is a fluid or concentrate source from which a base solution can be obtained.
The term “bicarbonate source” refers to a source of bicarbonate ions in solid and/or solution form. The bicarbonate ions can be present as a bicarbonate salt of any type. The bicarbonate source can contain at least one fluid pathway and include components such as conduits, valves, filters or fluid connection ports, any of which are fluidly connectable to each other or to a fluid flow path. The bicarbonate source can either be formed as a stand-alone enclosure or a compartment integrally formed with an apparatus containing the bicarbonate source.
A “brine source” is a fluid or concentrate source from which a brine solution can be obtained. As used herein, a brine solution can refer to any solution comprising acids, bases and/or salts.
A “carbon dioxide source” refers to a reservoir, a pressurized cylinder, or tank containing carbon dioxide gas.
The term “comprising” includes, but is not limited to, whatever follows the word “comprising.” Use of the term indicates the listed elements are required or mandatory but that other elements are optional and may be present.
The terms “conditioning” or “to condition” refer to processes designed to allow safe and effective use of a component in dialysis.
A “conditioning solution,” as used herein, is a solution containing bicarbonate ions for use in conditioning a zirconium oxide module.
A “connector” and “for connection” describe the concept of forming a fluid connection between two components wherein fluid, gas, or mixture of both gas and fluid can flow from one component, through a connector or a component for connection, to another component. The connector provides for a fluid connection in its broadest sense and can include any type of tubing, fluid or gas passageway, or conduit between any one or more components of the invention. The connection can optionally be disconnected and then reconnected.
The term “consisting of” includes and is limited to whatever follows the phrase “consisting of.” The phrase indicates the limited elements are required or mandatory and that no other elements may be present.
The term “consisting essentially of” includes whatever follows the term “consisting essentially of” and additional elements, structures, acts or features that do not affect the basic operation of the apparatus, structure or method described.
A “control system” can be a combination of components that act together to maintain a system to a desired set of performance specifications. The control system can use processors, memory and computer components configured to interoperate to maintain the desired performance specifications. The control system can also include fluid or gas control components, and solute control components as known within the art to maintain the performance specifications.
The term “desired zirconium oxide effluent pH” refers to a preferred pH range for fluid exiting a zirconium oxide module during dialysis.
The terms “determining” and “determine” refer to ascertaining a particular state or desired state of a system or variable(s).
A “dialysate flow path” is a route in which a fluid will travel during dialysis.
The term “disinfectant solution” refers to any solution capable of destroying or removing bacterial contaminants from a reusable sorbent module.
The terms “disinfecting,” “disinfected,” or to “disinfect” refer to removing bacterial contaminants from a component or system.
A “flow path” is one or more connectors or components through which fluid can travel.
The term “fluid” can be any substance that has no fixed shape that yields easily to external pressure such as a gas or a liquid. Specifically, the fluid can be water containing any solutes at any concentration.
The term “fluidly connectable,” “fluidly connected,” and “for fluid connection” refer to the ability to pass fluid or gas from one point to another point. The two points can be within or between any one or more of compartments, modules, systems, components, and rechargers, all of any type. The connection can optionally be disconnected and then reconnected.
A “fluid connector,” “fluid connection,” and the like describe a connection between two components wherein fluid or gas can flow from one component, through a connector or a component for connection, to another component. The connector provides for a fluid connection in its broadest sense and can include any type of tubing, fluid or gas passageway, or conduit between any one or more components of the invention. The connection can optionally be disconnected and then reconnected.
The terms “generating” or “to generate” refer to creating a fluid with a specified concentration, pH, temperature, and/or volume from one or more fluid sources.
The term “mixing” or “to mix” generally refers to causing two or more fluids from any source to combine together. For example, “mixing” can include turbulent flow at a location in a fluid line or a junction. Another example of “mixing” can include receiving one or more fluids in a component configured to receive fluids from one or multiple sources and to mix the fluids together in the component. Yet another example of “mixing” includes one or more fluids used in dissolution of one or more solid components to be dissolved in one or more fluids.
A “module inlet” is a connector through which a fluid, slurry, or aqueous solution can enter a sorbent module.
A “module outlet” is a connector through which a fluid, slurry, or aqueous solution can exit a sorbent module.
The term “pH sensor” refers to a device for measuring the pH or H+ concentration of a liquid in a vessel, container, or fluid line.
The term “pressure sensor” refers to a device for measuring the pressure of a gas or liquid in a vessel, container, or fluid line.
The term “pump” refers to any device that causes the movement of fluids or gases by applying suction or pressure.
The terms “pumping,” “pumped,” or to “pump” refer to moving a fluid with a pump.
“Recharging” refers to treating a sorbent material to restore the functional capacity of the sorbent material to put the sorbent material back into a condition for reuse or use in a new dialysis session. In some instances, the total mass, weight and/or amount of “rechargeable” sorbent materials remain the same. In some instances, the total mass, weight and/or amount of “rechargeable” sorbent materials change. Without being limited to any one theory of invention, the recharging process may involve exchanging ions bound to the sorbent material with different ions, which in some instances may increase or decrease the total mass of the system. However, the total amount of the sorbent material will in some instances be unchanged by the recharging process. Upon a sorbent material undergoing “recharging,” the sorbent material can then be said to be “recharged.”
A “recharging flow path” is a path through which fluid can travel while recharging sorbent material in a reusable sorbent module.
A “receiving compartment” is a space within a recharger or other apparatus into which a sorbent module to be recharged is placed.
The term “saturated” refers to a solution containing the greatest amount of a solute under given operating conditions.
The term “solid sodium bicarbonate” refers to sodium bicarbonate in the solid phase, and can include either granular, crystalline, or powdered forms, or combinations thereof, of the sodium bicarbonate.
A “sorbent cartridge module” or “sorbent module” means a discreet component of a sorbent cartridge. Multiple sorbent cartridge modules can be fitted together to form a sorbent cartridge of two, three, or more sorbent cartridge modules. In some embodiments, a single sorbent cartridge module can contain all of the necessary materials for dialysis. In such cases, the sorbent cartridge module can be a “sorbent cartridge.”
A sorbent “recharger” is an apparatus designed to recharge at least one sorbent material.
A “static mixer” is a component configured to receive fluids from one or multiple sources and to mix the fluids together. The static mixer may include components that agitate the fluids to further mixing.
“Zirconium oxide”, also known as hydrous zirconium oxide, is a sorbent material that removes anions from a fluid, exchanging the removed anions for different anions.
A “zirconium oxide sorbent module” is a sorbent module containing zirconium oxide.
“Zirconium phosphate” is a sorbent material that removes cations from a fluid, exchanging the removed cations for different cations.
A “zirconium phosphate sorbent module” is a sorbent module containing zirconium phosphate.
Zirconium Oxide Conditioning
The invention is drawn to systems and methods for conditioning a zirconium oxide sorbent module after recharging for reuse in dialysis.
The conditioning solution is pumped through the zirconium oxide sorbent module 102 for a sufficient length of time to ensure complete conditioning. The conditioning solution can be pumped through the zirconium oxide sorbent module 102 for any length of time including between any of 5 and 30 minutes, 5 and 10 minutes, 5 and 8 minutes, 7 and 10 minutes, 8 and 12 minutes, 10 and 15 minutes, 10 and 30 minutes, 15 and 25 minutes, or 20 and 30 minutes.
During dialysis, the zirconium oxide sorbent module 102 is used with zirconium phosphate and other sorbent materials for regeneration of dialysate. To simplify therapy and therapy modeling, equilibration of the zirconium oxide module with the zirconium phosphate is desired. The equilibration of zirconium phosphate and zirconium oxide means the pH of the zirconium oxide and zirconium phosphate effluents during therapy are the same. For example, if a desired zirconium phosphate effluent pH is determined to be 6.5, then the desired zirconium oxide effluent pH can also be 6.5 and the conditioning process can use a bicarbonate solution at a pH of 6.5 to place the zirconium phosphate and zirconium oxide sorbent modules in an equilibrium state. However, the zirconium oxide can be conditioned to any desired zirconium oxide effluent pH by using a bicarbonate solution at the desired zirconium oxide effluent pH.
The bicarbonate in bicarbonate source 106 can include bicarbonate ions in solid and/or solution form. For example, a bicarbonate dry cartridge may be included in bicarbonate source 106. Water can be added to the bicarbonate source 106 to dissolve the bicarbonate in the dry cartridge, or flowed through the dry cartridge, generating a bicarbonate solution of known concentration for use in conditioning. Alternatively, bicarbonate source 106 can include a premade bicarbonate solution.
The concentration of the bicarbonate in bicarbonate source 106 can be any concentration leading to a desired zirconium oxide effluent pH. In certain embodiments, the concentration of bicarbonate used in conditioning the zirconium oxide can be between 0.1 M and saturated, between 0.1 M and 1.0 M, between 0.5 M and 1.0 M, between 0.5 M and 2.0 M, between 1.0 M and saturated, or between 2.0 and saturated. The desired zirconium oxide effluent pH can be any pH, and in a preferred embodiment is between 5.0 and 7.5. In certain embodiments, the desired zirconium effluent pH can be between any of 5.0 and 6.0, between 5.0 and 6.5, between 5.5 and 6.5, between 5.5 and 7.0, between 6.0 and 7.5, or between 6.5 and 7.5. In certain embodiments, the conditioning solution can be heated to a specified temperature while conditioning the zirconium oxide. The conditioning solution can be heated to any temperature between 20 and 100° C., including between 20 and 35° C., between 20 and 50° C., between 40 and 60° C., between 40 and 80° C., between 50 and 75° C., or between 50 and 100° C. Approximately 4 mmoles of bicarbonate per gram of zirconium oxide is necessary for full conditioning of a zirconium oxide sorbent module with a phosphate capacity of about 0.8 mmoles phosphate/g of zirconium oxide. One of ordinary skill in the art will understand more bicarbonate will be necessary for a zirconium oxide module containing more zirconium oxide, or having a higher phosphate capacity. For example, the bicarbonate solution can be a 1M bicarbonate solution at a pH of 6.5, requiring 1.3 L of conditioning solution. At higher concentrations, less conditioning solution will be required. However, because significant carbon dioxide gas will be in equilibrium with the bicarbonate at a pH of around 6.5, a high pressure is required to create a stable 6.5 pH bicarbonate solution at high concentration. If the pressure is not high enough, degassing and release of carbon dioxide will occur. The concentration and volume of the bicarbonate conditioning solution used can be based on the desired zirconium oxide effluent pH and the pressure capabilities of the system. The conditioning solution used can be any volume, including between any of 0.5 and 20.0 L, 0.5 and 1.0 L, 0.75 and 1.25 L, 1.0 and 1.5 L, 1.0 and 5.0 L, 2.5 and 7.5 L, 5.0 and 15.0 L, 5.0 and 20.0 L, or 10.0 and 20.0 L. Although the recharging flow path 101 is illustrated as a flow path for both recharging and conditioning a zirconium oxide sorbent module 102, one of skill in the art will understand that a separate conditioning apparatus can be constructed without base source 105 solely for conditioning of the zirconium oxide sorbent module 102.
The conditioning solution containing sodium bicarbonate at a desired zirconium oxide effluent pH can be provided in a pre-mixed bicarbonate source 106 at the proper pH, as illustrated in
After recharging of both the zirconium oxide sorbent module 502 and zirconium phosphate sorbent module 506, the zirconium oxide sorbent module 502 can be conditioned. Bicarbonate solution from bicarbonate source 510 can be pumped through the zirconium phosphate sorbent module 506, generating a bicarbonate solution at the desired zirconium oxide effluent pH. Valve 515 can be switched to direct the bicarbonate solution into fluid connector 518 and to valve 512 in the zirconium oxide recharging flow path 501. The bicarbonate solution is pumped from valve 512 through the zirconium oxide sorbent module 502 to condition the zirconium oxide sorbent module 502.
Conditioning the zirconium oxide sorbent module 602 during priming requires additional bicarbonate in the dialysis system and lengthens the time necessary for priming. The additional amount of bicarbonate solution needed for conditioning during priming can be about 80 to 120 g of sodium bicarbonate. Conditioning the zirconium oxide sorbent module 602 during priming also adds between 5-15 minutes to the priming process. Conditioning the zirconium oxide sorbent module 602 in a recharger or a separate conditioning system allows a smaller bicarbonate source for therapy and a faster priming process. In any embodiment, the zirconium oxide sorbent module 602 can be conditioned partly in a recharger or conditioning system, and partly during priming, reducing the additional bicarbonate necessary during priming of the system. After conditioning, excess sodium bicarbonate can be rinsed into drain line 609 by pump 610 or used in subsequent priming steps. The drain line 609 can be fluidly connected to a drain reservoir 611, or alternatively, directly to a drain (not shown).
Conditioning the zirconium oxide sorbent module 702 with a conditioning solution formed by dissolving solid sodium bicarbonate in sorbent module 703 requires a quantity of sodium bicarbonate to be initially present in the sorbent module 703. The amount of bicarbonate present in sorbent module 703 can be any amount sufficient to fully condition the zirconium oxide sorbent module 702. In certain embodiments, the amount of sodium bicarbonate placed in sorbent module 703 can be between 40 and 130 grams, between 40 and 60 grams, between 50 and 100 grams, between 50 and 130 grams, between 75 and 100 grams, or between 80 and 130 grams. The necessary amount of sodium bicarbonate can vary depending on the size of zirconium oxide sorbent module 702. In certain embodiments, an excess of sodium bicarbonate beyond that necessary for conditioning zirconium oxide sorbent module 702 can be placed in sorbent module 703. After conditioning, the excess bicarbonate can be rinsed from the dialysate flow path 701 into drain line 711 by pump 712 or used in subsequent priming steps. After generation of the bicarbonate solution the bicarbonate solution can be recirculated within dialysate flow path 701 in order to maximize the utilization of bicarbonate during priming. The drain line 711 can be fluidly connected to a drain reservoir 713, or alternatively, directly to a drain (not shown).
As described, the pH of the conditioning solution can be the same pH as the effluent from the zirconium phosphate sorbent module subsequently used in dialysis.
Although shown with receiving compartments 902 and 904 for both a zirconium oxide and zirconium phosphate sorbent module in
As illustrated in
One skilled in the art will understand that various combinations and/or modifications and variations can be made in the described systems and methods depending upon the specific needs for operation. Moreover features illustrated or described as being part of an aspect of the invention may be used in the aspect of the invention, either alone or in combination, or follow a preferred arrangement of one or more of the described elements.
Hobot, Christopher M., Pudil, Bryant J.
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
10695481, | Aug 02 2011 | Mozarc Medical US LLC | Hemodialysis system having a flow path with a controlled compliant volume |
10981148, | Nov 29 2016 | Mozarc Medical US LLC | Zirconium oxide module conditioning |
1617288, | |||
2703313, | |||
3608729, | |||
3617545, | |||
3617558, | |||
3669878, | |||
3669880, | |||
3776819, | |||
3840835, | |||
3850835, | |||
3884808, | |||
3902490, | |||
3989622, | Dec 30 1970 | CCI Life Systems, Inc. | Urease in insoluble form for converting urea present in a liquid |
4060485, | Jun 09 1975 | I T L Technology, Inc. | Dialysis apparatus |
4073725, | May 09 1975 | Hitachi, Ltd. | Method and apparatus for liquid chromatography under elevated pressure |
4094775, | Feb 28 1977 | California Institute of Technology | Dialysis system |
4142845, | Feb 20 1976 | Dialysis pump system having over-center cam tracks to lock rollers against tubing | |
4192748, | Jul 05 1973 | Dialysis apparatus with selective chemical activity | |
4206054, | Oct 27 1978 | Pyramidic aquarium filter-aerator | |
4209392, | May 15 1978 | Portable hepatic-assist method and apparatus for same | |
4269708, | May 03 1978 | Hemodialysis and/or ultrafiltration apparatus | |
4371385, | Apr 28 1981 | Gambro, Inc | Deaerating liquid |
4374382, | Jan 16 1981 | Medtronic, Inc. | Marker channel telemetry system for a medical device |
4376707, | May 21 1979 | Gambro Dialysatoren KG | Process for the removal of urea from blood wash fluids and blood |
4381999, | Apr 28 1981 | Gambro, Inc | Automatic ultrafiltration control system |
4460555, | Aug 25 1983 | Gambro, Inc | Ammonia scavenger |
4556063, | Oct 07 1980 | Medtronic, Inc. | Telemetry system for a medical device |
4562751, | Jan 06 1984 | MEDTRONIC MINIMED, INC | Solenoid drive apparatus for an external infusion pump |
4581141, | Feb 27 1978 | HEMOCLEANSE, INC , A CORP OF IN | Dialysis material and method for removing uremic substances |
4612122, | Jun 29 1981 | HEMEX, INC | Removing heavy metal ions from blood |
4650587, | Sep 09 1982 | Gambro, Inc | Ammonia scavenger |
4661246, | Oct 01 1984 | HemoCleanse Technologies, LLC | Dialysis instrument with dialysate side pump for moving body fluids |
4678408, | Jan 06 1984 | MEDTRONIC MINIMED, INC | Solenoid drive apparatus for an external infusion pump |
4684460, | Dec 14 1984 | Haemodialysis device automatically monitoring loss of weight | |
4685903, | Jan 06 1984 | MEDTRONIC MINIMED, INC | External infusion pump apparatus |
4687582, | Dec 23 1985 | Method and apparatus for operating and regenerating ion exchangers | |
4750494, | May 12 1981 | Medtronic, Inc. | Automatic implantable fibrillation preventer |
4765907, | Mar 28 1984 | Research Development Systems, Inc. | Wearable, continuously internally operable and externally regenerable dialysis device |
4826663, | May 15 1985 | ENIRICERCHE S P A | Zirconium phosphate and method for its preparation |
4828693, | Sep 22 1987 | Baxter Travenol Laboratories, Inc. | Water pressure regulator for hemodialysis apparatus |
5032615, | Oct 31 1989 | Regents of the University of California, The | Continuous hemodialysis using citrate |
5047014, | Apr 15 1989 | B. Braun Melsungen AG | Medical pump device |
5080653, | Apr 16 1990 | MEDTRONIC MINIMED, INC | Infusion pump with dual position syringe locator |
5092886, | Sep 29 1987 | Implantable artificial kidney | |
5097122, | Apr 16 1990 | MEDTRONIC MINIMED, INC | Medication infusion system having optical motion sensor to detect drive mechanism malfunction |
5127404, | Jan 22 1990 | Medtronic, Inc. | Telemetry format for implanted medical device |
5192132, | Dec 12 1991 | Mobil Oil Corporation | Temperature monitoring of a fixed-bed catalytic reactor |
5230702, | Jan 16 1991 | Paradigm Biotechnologies Partnership | Hemodialysis method |
5284470, | Nov 02 1992 | Wearable, portable, light-weight artificial kidney | |
5302288, | Mar 19 1993 | SIEMENS ENERGY, INC | Treatment of highly colored wastewaters |
5305745, | Jun 13 1988 | Device for protection against blood-related disorders, notably thromboses, embolisms, vascular spasms, hemorrhages, hemopathies and the presence of abnormal elements in the blood | |
5308315, | Jul 27 1993 | KHURI, SOUMAYA M | Method for determining the adequacy of dialysis |
5318750, | Feb 14 1992 | Device for the preparation of a solution for medical use | |
5399157, | Jul 06 1992 | GAMBRO INDUSTRIES | Method for checking the operation of sensors situated in a dialysis liquid circuit |
5441049, | Dec 28 1992 | Automata Medical Instrumentation, Inc. | Conductivity meter |
5442969, | Oct 13 1992 | Baxter International Inc. | Fluid sampling module |
5445610, | Jan 15 1993 | University of Cincinnati | Portable peritoneal dialysis cycler |
5468388, | Jul 01 1993 | Sartorius Stedim Biotech GmbH | Filter module with degassing feature |
5507723, | May 24 1994 | Baxter International, Inc. | Method and system for optimizing dialysis clearance |
5662806, | Oct 13 1992 | Baxter International Inc. | Hemodialysis monitoring system for hemodialysis machines |
5683432, | Jan 11 1996 | Medtronic, Inc | Adaptive, performance-optimizing communication system for communicating with an implanted medical device |
5685835, | Jun 07 1995 | GAMBRO RENAL PRODUCTS, INC | Technique for using a dialysis machine to disinfect a blood tubing set |
5685988, | Sep 15 1993 | Dialysis process and system | |
5716400, | Dec 21 1989 | Smith & Nephew, Inc. | Cardiovascular implants of enhanced biocompatibility |
5744031, | Sep 10 1991 | GAMBRO INDUSTRIES | Artificial kidney provided with means for determining characteristics of blood |
5762782, | Feb 13 1995 | Baxter International Inc; BAXTER HEALTHCARE SA | Water treatment for dialysate preparation |
5770086, | Jan 25 1996 | EUREKA! SCIENCE CORP | Methods and apparatus using hydrogels |
5849179, | Oct 13 1992 | Baxter International Inc | Automatic apparatus for obtaining equilibration samples of dialysate |
5858186, | Dec 20 1996 | Lawrence Livermore National Security LLC | Urea biosensor for hemodialysis monitoring |
5938634, | Sep 08 1995 | Baxter International Inc. | Peritoneal dialysis system with variable pressure drive |
5938938, | Jul 04 1995 | BAXTER HEALTHCARE SA | Automatic dialysis method and apparatus |
5944684, | Aug 31 1995 | DEPARTMENT OF VETERANS AFFAIRS, UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE | Wearable peritoneum-based system for continuous renal function replacement and other biomedical applications |
6036858, | Jul 03 1995 | Baxter International Inc | Device in a dialysis machine |
6048732, | Oct 16 1996 | TEXAS SYSTEM, UNIVERSITY OF, THE, BOARD OF REGENTS | Receptor and method for citrate determination |
6052622, | Feb 12 1998 | Pacesetter AB | Heart stimulator with an evoked response detector |
6058331, | Apr 27 1998 | Medtronic, Inc. | Apparatus and method for treating peripheral vascular disease and organ ischemia by electrical stimulation with closed loop feedback control |
6114176, | Jul 29 1994 | Gambro Lundia AB | Method for measuring the concentration of a substance in a solution |
6126831, | Aug 13 1997 | Fresenius Medical Care Deutschland GmbH | Method and device for determining hemodialysis parameters |
6171480, | Jun 24 1996 | Board of Regents, The University of Texas System | Automated closed recirculating aquaculture filtration system |
6230059, | Mar 17 1999 | Medtronic, Inc. | Implantable monitor |
6248093, | Oct 29 1998 | MEDTRONIC MINIMED, INC | Compact pump drive system |
6254567, | Feb 26 1999 | NXSTAGE MEDICAL, INC | Flow-through peritoneal dialysis systems and methods with on-line dialysis solution regeneration |
6321101, | Oct 29 1997 | Pacesetter AB | Method and device for determination of concentration |
6362591, | Oct 29 1998 | MEDTRONIC MINIMED, INC | Method and apparatus for detection of occlusions |
6363279, | Jan 08 1996 | SANDLEFORD PARK LIMITED, AS SECURITY AGENT | Electrical muscle controller |
6390969, | Oct 09 1997 | THORATEC LLC; TC1 LLC | Implantable heart assist system and method of applying same |
6491993, | Aug 12 1999 | PACTIV LLC | Absorbent pouches |
6521184, | Jul 29 1994 | Gambro Lundia AB | Apparatus for measuring a decomposable compound in solution |
6554798, | Aug 18 1998 | MEDTRONIC MINIMED, INC | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
6555986, | Oct 29 1998 | MiniMed Inc. | Method and apparatus for detection of occlusions |
6565525, | May 15 1997 | Vasca, Inc. | Valve port assembly with interlock |
6572769, | Sep 26 1994 | Zero Technologies, LLC | Water treatment apparatus |
6579460, | Mar 13 2001 | UOP LLC | Process and composition for removing toxins from bodily fluids |
6585675, | Nov 02 2000 | Gambro Lundia AB | Method and apparatus for blood withdrawal and infusion using a pressure controller |
6589229, | Jul 31 2000 | Becton, Dickinson and Company | Wearable, self-contained drug infusion device |
6593747, | Oct 05 1998 | LANXESS INC | Method and apparatus for monitoring adsorbent activity in situ |
6596234, | Jun 10 1998 | HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT | Reversing flow blood processing system |
6602399, | Mar 22 2000 | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E V | Signal recording of a receptor-effector-system by an extracellular planar potential-sensitive electrode |
6627164, | Nov 28 2000 | RENAL SOLUTIONS, INC | Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same |
6666840, | Jun 04 1998 | AS LDIAMON | Method for determining waste products in the dialysis liquid in dialysis treatment |
6676608, | Apr 19 2000 | Baxter International Inc; BAXTER HEALTHCARE SA | Method and apparatus for monitoring the cardiovascular condition, particularly the degree of arteriosclerosis in individuals |
6695807, | Jan 18 2002 | HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT | Blood flow reversing system |
6711439, | Feb 14 2002 | Pacesetter, Inc. | Evoked response variability as an indicator of autonomic tone and surrogate for patient condition |
6719745, | Mar 26 1999 | Prismedical Corporation | Water purification pack |
6773412, | Apr 13 2001 | Gambro Lundia AB | User interface for blood treatment device |
6814724, | Mar 26 1999 | Prismedical Corporation | Water purification pack |
6818196, | Nov 28 2000 | Renal Solutions, Inc. | Zirconium phosphate and method of making the same |
6861266, | Dec 09 1997 | Gambro Lundia AB | Method and device for calculating dialysis efficiency |
6878258, | Feb 11 2002 | Applied Materials, Inc.; Applied Materials, Inc | Apparatus and method for removing contaminants from semiconductor copper electroplating baths |
6878283, | Nov 28 2001 | SORB TECHNOLOGY, INC ; RENAL SOLUTIONS, INC | Filter cartridge assemblies and methods for filtering fluids |
6878285, | Apr 17 2002 | WATERVISIONS INTERNATIONAL, INC | Ion-exchange based fluid treatment systems |
6890315, | May 23 2000 | Gambro Lundia AB | Method and apparatus for vein fluid removal in heart failure |
6923782, | Apr 13 2001 | Gambro Lundia AB | User interface for blood treatment device |
6960179, | Nov 16 2001 | FRESENIUS MEDICAL CARE HOLDINGS, INC | Wearable continuous renal replacement therapy device |
7029456, | Oct 15 2003 | Baxter International Inc; BAXTER HEALTHCARE S A | Medical fluid therapy flow balancing and synchronization system |
7033498, | Nov 28 2000 | RENAL SOLUTIONS, INC | Cartridges useful in cleaning dialysis solutions |
7077819, | Dec 24 1998 | Fresenius Medical Care Deutschland GmbH | Method for determining the distribution volume of a blood component during an extracorporeal blood treatment and device for carrying out the method |
7097630, | Jan 07 1998 | Fresenius Medical Care North America | Method and apparatus for determining hemodialysis parameters |
7101519, | Nov 28 2000 | Renal Solutions, Inc. | Zirconium basic carbonate and methods of making the same |
7128750, | Jul 19 1999 | APOLLO ENDOSURGERY US, INC | Flow control method and device |
7153693, | Feb 22 2002 | Toyo Engineering Corporation | Method and apparatus for determining urea concentration |
7208092, | Jul 19 2002 | Baxter International Inc.; Baxter Healthcare S.A. | Systems and methods for peritoneal dialysis |
7241272, | Nov 13 2001 | Baxter International Inc. | Method and composition for removing uremic toxins in dialysis processes |
7276042, | Jan 23 2003 | FRESENIUS MEDICAL CARE HOLDINGS, INC | Low hydraulic resistance cartridge |
7309323, | Nov 16 2001 | FRESENIUS MEDICAL CARE HOLDINGS, INC | Wearable continuous renal replacement therapy device |
7318892, | Apr 19 1991 | Baxter International Inc. | Method and apparatus for kidney dialysis |
7326576, | Apr 09 2003 | PRESCIENT MEDICAL, INC | Raman spectroscopic monitoring of hemodialysis |
7384543, | Oct 31 2003 | Gambro Lundia AB | Circuit for extracorporeal blood treatment and flow-inverting device utilized therein |
7435342, | Dec 24 2003 | Chemica Technologies, Inc. | Dialysate regeneration system for portable human dialysis |
7462161, | Nov 02 2000 | Gambro Lundia AB | Method and apparatus for blood withdrawal and infusion using a pressure controller |
7488447, | Oct 30 2002 | Gambro Lundia AB | Method and an apparatus for determining the efficiency of dialysis |
7537688, | Aug 24 2004 | NIKKISO CO., LTD. | Blood purification device |
7544300, | Jan 07 2003 | Medherant Limited | Batch filtration system for preparation of sterile fluid for renal replacement therapy |
7544737, | Feb 28 2003 | Baxter International Inc.; Baxter Healthcare S.A. | Macromolecular ketoaldehydes |
7563240, | Apr 11 2003 | Fresenius Medical Care Deutschland GmbH | Haemodialysis device |
7566432, | Dec 28 2004 | Renal Solutions, Inc. | Method of synthesizing zirconium phosphate particles |
7575564, | Oct 28 2003 | Baxter International Inc; BAXTER HEALTHCARE S A | Priming, integrity and head height methods and apparatuses for medical fluid systems |
7597806, | May 23 2005 | ASAHI KASEI MEDICAL CO , LTD | Body fluid treating filter device |
7674231, | Aug 22 2005 | Massachusetts Institute of Technology | Wearable pulse wave velocity blood pressure sensor and methods of calibration thereof |
7674237, | Nov 02 2000 | Gambro Lundia AB | Method and apparatus for blood withdrawal and infusion using a pressure controller |
7686778, | Jan 15 2003 | HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT | Waste balancing for extracorporeal blood treatment systems |
7704361, | Dec 12 2000 | CARLSBERG A S | Method and apparatus for isolation of ionic species from a liquid |
7736507, | Dec 28 2004 | Renal Solutions, Inc. | Method of synthesizing zirconium phosphate particles |
7754852, | Jul 20 2007 | Mayo Foundation for Medical Education and Research | Natriuretic polypeptides |
7756572, | Jan 25 2005 | Pacesetter, Inc. | System and method for efficiently distinguishing among cardiac ischemia, hypoglycemia and hyperglycemia using an implantable medical device and an external system |
7776001, | Nov 29 1999 | HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT | Registration of fluid circuit components in a blood treatment device |
7776006, | Nov 05 2003 | BAXTER HEALTHCARE S A | Medical fluid pumping system having real time volume determination |
7776210, | Jun 09 2004 | Renal Solutions, Inc. | Dialysis system |
7794141, | Apr 14 2006 | DEKA Products Limited Partnership | Thermal and coductivity sensing systems, devices and methods |
7794419, | May 18 2005 | Gambro Lundia AB | Apparatus for controlling blood flow in an extracorporeal circuit |
7850635, | Jan 23 2003 | FRESENIUS MEDICAL CARE HOLDINGS, INC | Low hydraulic resistance cartridge |
7867214, | Jul 19 2002 | BAXTER HEALTHCARE S A | Systems and methods for performing peritoneal dialysis |
7901376, | Jul 05 2007 | BAXTER HEALTHCARE S A | Dialysis cassette having multiple outlet valve |
7905853, | Oct 30 2007 | BAXTER HEALTHCARE S A | Dialysis system having integrated pneumatic manifold |
7922686, | Jul 19 2002 | BAXTER HEALTHCARE S A | Systems and methods for performing peritoneal dialysis |
7922911, | Jul 19 2002 | BAXTER HEALTHCARE S A | Systems and methods for peritoneal dialysis |
7947179, | Jun 09 2004 | Renal Solutions, Inc. | Dialysis system |
7955289, | Nov 02 2000 | Gambro Lundia AB | Method and apparatus for blood withdrawal and infusion using a pressure controller |
7955290, | Nov 13 2001 | Baxter International Inc. | Method and composition for removing uremic toxins in dialysis processes |
7967022, | Feb 27 2007 | DEKA Products Limited Partnership | Cassette system integrated apparatus |
7981082, | Aug 21 2007 | ICU Medical, Inc | System and method for reducing air bubbles in a fluid delivery line |
7988854, | Dec 24 2003 | Chemica Technologies, Inc. | Dialysate regeneration system for portable human dialysis |
8002726, | Nov 13 2001 | Baxter International Inc. | Method and composition for removing uremic toxins in dialysis processes |
8012118, | Mar 08 2007 | FRESENIUS MEDICAL CARE HOLDINGS, INC | Artificial kidney dialysis system |
8029454, | Nov 05 2003 | Baxter International Inc; BAXTER HEALTHCARE S A | High convection home hemodialysis/hemofiltration and sorbent system |
8034161, | Jan 18 2008 | FRESENIUS MEDICAL CARE HOLDINGS, INC | Carbon dioxide gas removal from a fluid circuit of a dialysis device |
8066658, | Nov 13 2001 | Baxter International Inc. | Method and composition for removing uremic toxins in dialysis processes |
8070709, | Oct 28 2003 | Baxter International Inc.; Baxter Healthcare S.A. | Peritoneal dialysis machine |
8080161, | Jun 11 2009 | Baxter International Inc.; Baxter Healthcare S.A. | Dialysis treatment devices for removing urea |
8087303, | Sep 06 2007 | DEKA Products Limited Partnership | Product dispensing system |
8096969, | Jan 30 2007 | The Regents of the University of California; The United States of America as represented by the United States Department of Veterans Affairs | Peritoneal dialysis methods and apparatus |
8180574, | Jul 07 2009 | Baxter International; Baxter Healthcare S.A. | Simplified peritoneal equilibration test for peritoneal dialysis |
8182673, | Jan 29 2009 | Baxter International Inc.; Baxter Healthcare S.A.; Baxter International Inc; BAXTER HEALTHCARE S A | Drain and fill logic for automated peritoneal dialysis |
8183046, | Jan 11 2007 | The Board of Trustees of the University of Illinois | Temperature resistant pH buffers for use at low temperatures |
8187250, | Jan 30 2006 | The Regents of the University of California; The US Government Represented by the Department of Veterans Affairs | Peritoneal dialysis methods and apparatus |
8197439, | Jan 23 2008 | DEKA Products Limited Partnership | Fluid volume determination for medical treatment system |
8206591, | Oct 16 2008 | FRESENIUS MEDICAL CARE HOLDINGS, INC | Method of removing protein-bound deleterious substances during extracorporeal renal replacement treatment |
8211048, | Feb 22 2006 | HENRY FORD HEALTH SYSTEM | System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits |
8221529, | Oct 01 2007 | Baxter International; Baxter Healthcare S.A. | Dialysis systems and methods including cassette with air removal |
8226595, | May 26 2006 | Baxter International Inc; BAXTER HEALTHCARE S A | Automated dialysis system driven by gravity and vacuum |
8246826, | Feb 27 2007 | DEKA Products Limited Partnership | Hemodialysis systems and methods |
8267881, | Nov 02 2000 | Gambro Lundia AB | Method and apparatus for blood withdrawal and infusion using a pressure controller |
8273049, | Feb 27 2007 | DEKA Products Limited Partnership | Pumping cassette |
8292594, | Apr 14 2006 | DEKA Products Limited Partnership | Fluid pumping systems, devices and methods |
8303532, | Oct 18 2005 | JMS CO , LTD | Pertioneal membrane function test method, peritoneal membrane function test apparatus and peritoneal membrane function test program |
8313642, | Jul 09 2008 | Baxter International Inc.; Baxter Healthcare S.A. | Dialysis system including wireless patient data and trending and alert generation |
8317492, | Feb 27 2007 | DEKA Products Limited Partnership | Pumping cassette |
8357113, | Jul 19 2002 | Baxter International Inc.; Baxter Healthcare S.A. | Systems and methods for performing peritoneal dialysis |
8357298, | Feb 27 2007 | DEKA Products Limited Partnership | Hemodialysis systems and methods |
8366316, | Apr 14 2006 | DEKA Products Limited Partnership | Sensor apparatus systems, devices and methods |
8366655, | Apr 02 2007 | DEKA Products Limited Partnership | Peritoneal dialysis sensor apparatus systems, devices and methods |
8376999, | May 24 2002 | Baxter International Inc. | Automated dialysis system including touch screen controlled mechanically and pneumatically actuated pumping |
8377012, | Jan 30 2009 | Baxter International Inc; BAXTER HEALTHCARE S A | Transfer sets for therapy optimization |
8377308, | Dec 03 2007 | Hepa Wash GmbH | Dialysate regeneration unit |
8388567, | Apr 12 2007 | Gambro Lundia AB | Apparatus for extracorporeal blood treatment |
8404491, | Oct 29 2010 | Hewlett-Packard Development Company, L.P.; HEWLETT-PACKARD DEVELOPMENT COMPANY, L P | Luminescent chemical sensor integrated with at least one molecular trap |
8409441, | Feb 27 2007 | DEKA Products Limited Partnership | Blood treatment systems and methods |
8409444, | Sep 30 2008 | Fresenius Medical Care Holdings, Inc. | Acid zirconium phosphate and alkaline hydrous zirconium oxide materials for sorbent dialysis |
8449487, | Dec 01 2006 | Gambro Lundia AB | Blood treatment apparatus |
8480607, | Oct 27 2006 | UCL Business PLC | Therapy for liver disease |
8499780, | Feb 27 2007 | DEKA Products Limited Partnership | Cassette system integrated apparatus |
8518260, | Oct 01 2009 | FRESENIUS MEDICAL CARE HOLDINGS, INC | Method of controlling diffusive sodium transport in dialysis |
8535525, | May 06 2005 | Quanta Dialysis Technologies Limited | Fluid processing apparatus |
8580112, | Nov 16 2007 | FRESENIUS MEDICAL CARE HOLDINGS, INC | Dialysis systems and methods |
8597227, | Jul 19 2002 | Baxter International Inc.; Baxter Healthcare S.A. | Weight/sensor-controlled sorbent system for hemodialysis |
8647506, | Sep 30 2008 | Fresenius Medical Care Holdings, Inc. | Acid zirconium phosphate and alkaline hydrous zirconium oxide materials for sorbent dialysis |
8696626, | Jul 30 2008 | Debubbler | |
8733559, | Oct 03 2008 | Fresenius Medical Care Holdings, Inc. | Zirconium phosphate particles having improved adsorption capacity and method of synthesizing the same |
8764981, | Jun 11 2009 | Baxter International Inc.; Baxter Healthcare S.A. | Dialysis treatment devices for removing urea |
8777892, | Nov 03 2008 | FRESENIUS MEDICAL CARE HOLDINGS, INC | Portable peritoneal dialysis system |
8903492, | Feb 07 2005 | Mozarc Medical US LLC | Ion imbalance detector |
9144640, | Feb 02 2013 | Mozarc Medical US LLC | Sorbent cartridge configurations for improved dialysate regeneration |
9254355, | Aug 18 2011 | FRESENIUS MEDICAL CARE HOLDINGS, INC | Sorbent and chemical regeneration of dialysate |
9527015, | Mar 08 2010 | Unit, assembly and apparatus for treating fluid | |
20010007931, | |||
20010009756, | |||
20020016550, | |||
20020027106, | |||
20020042561, | |||
20020062098, | |||
20020112609, | |||
20020117436, | |||
20020147109, | |||
20030080059, | |||
20030097086, | |||
20030105435, | |||
20030113931, | |||
20030114787, | |||
20030138348, | |||
20030187479, | |||
20040019312, | |||
20040019320, | |||
20040030277, | |||
20040037986, | |||
20040054315, | |||
20040082903, | |||
20040084358, | |||
20040099593, | |||
20040127648, | |||
20040147900, | |||
20040168963, | |||
20040215090, | |||
20040257409, | |||
20050006296, | |||
20050056592, | |||
20050065760, | |||
20050101901, | |||
20050113796, | |||
20050126961, | |||
20050126998, | |||
20050131332, | |||
20050148923, | |||
20050150832, | |||
20050230313, | |||
20050234354, | |||
20050234381, | |||
20050274658, | |||
20060025661, | |||
20060037483, | |||
20060157413, | |||
20060189926, | |||
20060195064, | |||
20060217771, | |||
20060226079, | |||
20060241543, | |||
20060241709, | |||
20060264894, | |||
20070007208, | |||
20070055296, | |||
20070066928, | |||
20070138011, | |||
20070175827, | |||
20070179431, | |||
20070213665, | |||
20070215545, | |||
20070243113, | |||
20070255250, | |||
20080006570, | |||
20080011664, | |||
20080015493, | |||
20080021337, | |||
20080051696, | |||
20080053905, | |||
20080067132, | |||
20080215247, | |||
20080217245, | |||
20080241031, | |||
20080292935, | |||
20090012864, | |||
20090020471, | |||
20090078636, | |||
20090084199, | |||
20090101552, | |||
20090101577, | |||
20090120864, | |||
20090127193, | |||
20090149795, | |||
20090216045, | |||
20090266358, | |||
20090275849, | |||
20090275883, | |||
20090281484, | |||
20090282980, | |||
20100004588, | |||
20100007838, | |||
20100010429, | |||
20100018923, | |||
20100030151, | |||
20100051529, | |||
20100051552, | |||
20100076364, | |||
20100078381, | |||
20100078387, | |||
20100084330, | |||
20100094158, | |||
20100100027, | |||
20100101195, | |||
20100102190, | |||
20100114001, | |||
20100114012, | |||
20100137693, | |||
20100168546, | |||
20100168641, | |||
20100213127, | |||
20100217181, | |||
20100224492, | |||
20100234795, | |||
20100241045, | |||
20100252490, | |||
20100312172, | |||
20100312174, | |||
20100314314, | |||
20100326911, | |||
20110009798, | |||
20110017665, | |||
20110048949, | |||
20110066043, | |||
20110077574, | |||
20110079558, | |||
20110087187, | |||
20110130666, | |||
20110163034, | |||
20110171713, | |||
20110184340, | |||
20110220562, | |||
20110247973, | |||
20110272337, | |||
20110272352, | |||
20110297593, | |||
20110315611, | |||
20110315632, | |||
20120016228, | |||
20120018377, | |||
20120083729, | |||
20120085707, | |||
20120092025, | |||
20120095402, | |||
20120115248, | |||
20120220528, | |||
20120248017, | |||
20120258545, | |||
20120258546, | |||
20120273354, | |||
20120273415, | |||
20120273420, | |||
20120277546, | |||
20120277551, | |||
20120277552, | |||
20120277604, | |||
20120277650, | |||
20120277655, | |||
20120277722, | |||
20120303079, | |||
20130006128, | |||
20130018095, | |||
20130019179, | |||
20130020237, | |||
20130023812, | |||
20130025357, | |||
20130027214, | |||
20130028809, | |||
20130030347, | |||
20130030348, | |||
20130030356, | |||
20130037142, | |||
20130037465, | |||
20130056418, | |||
20130072895, | |||
20130075314, | |||
20130087210, | |||
20130110028, | |||
20130116578, | |||
20130199998, | |||
20130213890, | |||
20130213891, | |||
20130228516, | |||
20130274642, | |||
20130324915, | |||
20130330208, | |||
20130331774, | |||
20140001112, | |||
20140018728, | |||
20140042092, | |||
20140065950, | |||
20140088442, | |||
20140110340, | |||
20140110341, | |||
20140138294, | |||
20140158538, | |||
20140158588, | |||
20140158623, | |||
20140190876, | |||
20140190885, | |||
20140190886, | |||
20140190891, | |||
20140217028, | |||
20140217030, | |||
20140220699, | |||
20140251908, | |||
20140262812, | |||
20140326671, | |||
20140336568, | |||
20150057602, | |||
20150108069, | |||
20150114891, | |||
20150144539, | |||
20150144542, | |||
20150157960, | |||
20150238673, | |||
20150250937, | |||
20150251161, | |||
20150251162, | |||
20150258266, | |||
20150306292, | |||
20150367051, | |||
20150367052, | |||
20150367055, | |||
20150367056, | |||
20150367057, | |||
20150367058, | |||
20150367059, | |||
20150367060, | |||
20160236188, | |||
20160243299, | |||
20160243540, | |||
20160243541, | |||
20170087533, | |||
20180221852, | |||
CN102573618, | |||
CN102762268, | |||
CN103402563, | |||
CN103747818, | |||
CN103889478, | |||
CN104936633, | |||
CN105658326, | |||
CN105992599, | |||
CN106413878, | |||
CN1487853, | |||
DE102011052188, | |||
DE3110128, | |||
EP264695, | |||
EP266795, | |||
EP614081, | |||
EP906768, | |||
EP1085295, | |||
EP1345687, | |||
EP1345856, | |||
EP1364666, | |||
EP1450879, | |||
EP1545652, | |||
EP1592494, | |||
EP1684625, | |||
EP1701752, | |||
EP1938849, | |||
EP1991289, | |||
EP2100553, | |||
EP2142234, | |||
EP2219703, | |||
EP2344220, | |||
EP2446908, | |||
EP2550984, | |||
EP2564884, | |||
EP2564885, | |||
EP2575827, | |||
EP2576453, | |||
EP2701580, | |||
EP2701595, | |||
EP2701596, | |||
EP2950836, | |||
EP3546042, | |||
EP3626280, | |||
EP711182, | |||
JP2005511250, | |||
JP200744602, | |||
JP2013502987, | |||
JP2981573, | |||
JP490963, | |||
JP5070281, | |||
JP51131393, | |||
JP5155193, | |||
JP599464, | |||
JP61164562, | |||
WO57935, | |||
WO185295, | |||
WO14066254, | |||
WO14066255, | |||
WO14077082, | |||
WO2000038591, | |||
WO200066197, | |||
WO2001085295, | |||
WO200170307, | |||
WO2002043859, | |||
WO2003043677, | |||
WO2003043680, | |||
WO2003051422, | |||
WO2004008826, | |||
WO2004009156, | |||
WO2004030716, | |||
WO2004030717, | |||
WO2004062710, | |||
WO2004064616, | |||
WO2005123230, | |||
WO2007089855, | |||
WO2008075951, | |||
WO20090157877, | |||
WO2009026603, | |||
WO2009064984, | |||
WO2009157877, | |||
WO2009157878, | |||
WO2010028860, | |||
WO2010102190, | |||
WO2010141949, | |||
WO2011025705, | |||
WO2012060700, | |||
WO2012148781, | |||
WO2012148786, | |||
WO2012148789, | |||
WO2012162515, | |||
WO2012172398, | |||
WO2013019179, | |||
WO2013019994, | |||
WO2013022024, | |||
WO2013022837, | |||
WO2013025844, | |||
WO2013025957, | |||
WO2013027214, | |||
WO2013028809, | |||
WO2013030642, | |||
WO2013030643, | |||
WO2013101888, | |||
WO2013103607, | |||
WO2013103906, | |||
WO2013114063, | |||
WO2013121162, | |||
WO2014121162, | |||
WO2014121163, | |||
WO2014121167, | |||
WO2014121169, | |||
WO2015060914, | |||
WO2015142624, | |||
WO2015199764, | |||
WO2015199765, | |||
WO2015199863, | |||
WO2015199864, | |||
WO9106326, | |||
WO953201, | |||
WO9937342, | |||
WO2003041764, | |||
WO2005062973, | |||
WO20070103411, | |||
WO2011017215, | |||
WO2013019179, | |||
WO2013019994, | |||
WO2013025957, | |||
WO2013028809, | |||
WO2013103607, | |||
WO2013109922, | |||
WO2014121238, | |||
WO2015060914, | |||
WO2015080895, | |||
WO2015126879, | |||
WO2015199765, | |||
WO2015199863, | |||
WO2015199864, | |||
WO2016191039, | |||
WO2016191041, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Feb 09 2017 | HOBOT, CHRISTOPHER M | Medtronic, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 055865 | /0111 | |
Feb 09 2017 | PUDIL, BRYANT J | Medtronic, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 055865 | /0111 | |
Mar 10 2021 | Medtronic, Inc | (assignment on the face of the patent) | / | |||
Mar 28 2023 | Medtronic, Inc | Mozarc Medical US LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 063375 | /0659 |
Date | Maintenance Fee Events |
Mar 10 2021 | BIG: Entity status set to Undiscounted (note the period is included in the code). |
Date | Maintenance Schedule |
May 09 2026 | 4 years fee payment window open |
Nov 09 2026 | 6 months grace period start (w surcharge) |
May 09 2027 | patent expiry (for year 4) |
May 09 2029 | 2 years to revive unintentionally abandoned end. (for year 4) |
May 09 2030 | 8 years fee payment window open |
Nov 09 2030 | 6 months grace period start (w surcharge) |
May 09 2031 | patent expiry (for year 8) |
May 09 2033 | 2 years to revive unintentionally abandoned end. (for year 8) |
May 09 2034 | 12 years fee payment window open |
Nov 09 2034 | 6 months grace period start (w surcharge) |
May 09 2035 | patent expiry (for year 12) |
May 09 2037 | 2 years to revive unintentionally abandoned end. (for year 12) |